Surrozen, Inc. (SRZN)
NASDAQ: SRZN · Real-Time Price · USD
23.75
+0.24 (1.02%)
At close: Oct 14, 2026, 4:00 PM EDT
23.75
0.00 (0.00%)
After-hours: Oct 14, 2026, 4:46 PM EDT
Surrozen Market Cap
Surrozen has a market cap or net worth of $279.15 million as of October 14, 2026. It is the 18,909th most valuable company in the world and the 3,301st biggest in the United States. Its market cap has increased by 135.69% in one year.
Market Cap
279.15M
Enterprise Value
183.42M
1-Year Change
135.69%
Global Rank
Country Rank
#3,301 United States
Category
ChartMarket Cap Chart
Since January 11, 2021, Surrozen's market cap has increased from $120.65M to $279.15M, an increase of 131.36%. That is a compound annual growth rate of 15.68%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 14, 2026 | 279.15M | 32.49% |
| Dec 31, 2025 | 210.69M | 351.80% |
| Dec 31, 2024 | 46.63M | 143.39% |
| Dec 29, 2023 | 19.16M | 10.72% |
| Dec 30, 2022 | 17.31M | -92.33% |
| Dec 31, 2021 | 225.58M | 86.96% |
| Jan 11, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Fennec Pharmaceuticals | 375.57M |
| Enanta Pharmaceuticals | 364.07M |
| Relmada Therapeutics | 361.61M |
| Inhibikase Therapeutics | 358.69M |
| Orchestra BioMed Holdings | 357.63M |
| Turn Therapeutics | 357.46M |
| Agenus | 345.31M |
| Artiva Biotherapeutics | 339.30M |